DanDrit Overview
- Founded
- 2001

- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Financing Rounds
- 3
DanDrit General Information
Description
Enochian BioSciences Inc is a biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing gene therapies. It develops cures and providing prevention for infectious diseases and cancer. It is also engaged in developing HIV preventative vaccine and cures and Cellular immune-oncology products.
Contact Information
- 375 Park Avenue
- Suite 2607
- New York, NY 10152
- United States
DanDrit Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore DanDrit‘s full profile, request access.
Request a free trialDanDrit Comparisons
Industry
00000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialDanDrit Competitors (12)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Northwest Biotherapeutics | Corporation | Bethesda, MD | 00 | 00000 | 000000000 - | 00000 |
0000000000 | Corporate Backed or Acquired | Baton Rouge, LA | 000000000000 | |||
0000000 | Formerly VC-backed | Cambridge, MA | 00 | 00000 | 00000000 | 00000 |
0000000 0000000000 | Formerly VC-backed | Watertown, MA | 00 | 00000 | 000000000 | 00000 |
00000 | Private Equity-Backed | Prague, Czech Republic | 000 | 000000000000 |
DanDrit Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Luisa Puche | Chief Financial Officer & Principal Accounting Officer |